|
Volume 271,
Number 9,
Issue of March 1, 1996 pp. 5007-5016
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Biosynthesis of
the Unsaturated 14-Carbon Fatty Acids Found on the N Termini of
Photoreceptor-specific Proteins (*)
(Received for publication, October 3, 1995; and in revised form, December 11, 1995)
James C.
DeMar
Jr.
(1), (§),
Theodore G.
Wensel
(1),
Robert E.
Anderson
(2)(¶)From the
(1)Department of Biochemistry, Baylor
College of Medicine, Houston, Texas, 77030 and the
(2)Dean A. McGee Eye Institute, Oklahoma Center for
Neurosciences and the Department of Biochemistry and Molecular Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma,
73104
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
In the vertebrate retina, a number of proteins involved in
signal transduction are known to be N-terminal acylated with the
unusual 14 carbon fatty acids 14:1n-9 and 14:2n-6. We
have explored possible pathways for producing these fatty acids in the
frog retina by incubation in vitro with candidate precursor
fatty acids bearing radiolabels, including
[ H]14:0,
[ H]18:1n-9,
[ H]18:2n-6, and
[ H]18:3n-3. Rod outer segments were
prepared from the radiolabeled retinas for analysis of protein-linked
fatty acids, and total lipids were extracted from the remaining retinal
pellet. Following saponification of extracted lipids, fatty acid
phenacyl esters were prepared and analyzed by high pressure liquid
chromatography (HPLC) with detection by continuous scintillation
counting. Transducin, whose -subunit (G ) is known
to bear N-terminal acyl chains, was extracted from the rod outer
segments and subjected to SDS-polyacrylamide gel electrophoresis and
fluorography to detect radiolabeled proteins. G was
also subjected to methanolysis, and the resulting fatty acyl methyl
esters were analyzed by HPLC. The identities of HPLC peaks coinciding
with unsaturated species of both phenacyl esters and methyl esters were
confirmed by reanalyzing them after catalytic hydrogenation. The
results showed that 14:1n-9 can be derived in the retina from
18:1n-9 and 14:2n-6 from 18:2n-6, most
likely by two rounds of -oxidation, but that neither is produced
in detectable amounts from 14:0. Retroconversion of unsaturated 18
carbon fatty acids to the corresponding 14 carbon species showed
specificity, in that 18:3n-3 was not converted to 14 carbon
fatty acids in detectable amounts. Myristic acid (14:0),
14:1n-9, and 14:2n-6 were all incorporated into
G . A much less efficient incorporation of
18:1n-9 into G was also observed, but no
radiolabeling of G was observed in retinas incubated
with 18:3n-3. Thus, retroconversion by limited -oxidation
of longer chain unsaturated fatty acids appears to be the most likely
metabolic source of the unusual fatty acids found on the N termini of
signal transducing proteins in the retina.
INTRODUCTION
A number of proteins of both eukaryotic and viral origin are
modified by fatty acylation through an amide linkage to N-terminal
glycine residues (reviewed by James and Olson(1990), McIlhinney (1990),
Towler et al.(1988), Schlesinger(1993), and Gordon et
al.(1991)). This modification, which in the great majority of
cases studied involves the saturated 14 carbon fatty acid myristate
(14:0), has been shown to play an important role in the function of
these proteins (Jones et al., 1990; Linder et al.,
1991; Yonemoto et al., 1993; Wedegaertner et al.,
1995). In vertebrate retinas, the types of N-terminal fatty acids for
proteins involved in signal transduction are strikingly different from
those found in other tissues. These proteins, which include the
-subunit of the G protein transducin (G ) ( )(Johnson et al., 1994; Kokame et al.,
1992; Neubert et al., 1992; Yang and Wensel, 1992), guanylyl
cyclase-activating protein (GCAP) (Palczewski et al., 1994),
recoverin (Dizhoor et al., 1992; Johnson et al.,
1994), and the catalytic subunit of cAMP-dependent protein kinase
(Johnson et al., 1994), are heterogeneously acylated with
frequent occurrence of 14:1n-9 and 14:2n-6 in
addition to 14:0 and 12:0. This unusual pattern appears to reflect
unusual pathways for synthesizing and utilizing fatty acids for
N-terminal acylation in the retina rather than specific characteristics
of the acylated proteins. The ubiquitous protein kinase is exclusively
modified with 14:0 in the brain and heart (Carr et al., 1982;
Johnson et al., 1994) but in the retina shows the same
heterogeneous pattern of fatty acylation as G . Indeed,
although 12:0 and 14:0 are found in animal tissues, 14:1n-9
and 14:2n-6 are quite rare and have been found in abundance
only in marine mammals (14:1n-9) (Markley, 1960) and the Asian
plant Evodia rutaecarpa (14:2n-6) (Kurono et
al., 1972). It is conceivable that the two unsaturated fatty
acids could arise from the desaturation of 14:0. However, previously
described  -desaturase enzymes prefer long chain
polyunsaturated fatty acids as substrates (Numa et al., 1984),
and  -desaturases have only been found in a few cell
types, such as testicular Sertoli (Oulhaj et al., 1992) and
brain glioma cells (Cook et al., 1991). Alternatively, these
unusual 14-carbon fatty acids might arise by retroconversion from
longer chain fatty acids through partial -oxidation. For example,
18:1n-9 (oleic acid) or 18:2n-6 (linoleic acid) might
be converted by this route to 14:1n-9 and 14:2n-6,
respectively. Indeed, it has been hypothesized that 14:2n-6 is
generated within the photoreceptor cell in this manner (Hansen, 1993;
Wang and Anderson, 1993). Such partial -oxidation is
characteristic of peroxisomal metabolism in contrast to mitochondrial
-oxidation, which favors complete degradation to acetyl-CoA
(Schulz, 1991). Retroconversion pathways of this kind have been
demonstrated to convert 13-hydroxy-9,11-octadecadienoic acid (13-OH,
18:2n-6) to 9-hydroxy-5,7-tetradecadienoic acid (13-OH,
14:2n-6) in lymphocytes (Hadjuagapiiou et al., 1990)
and to 18:2n-6 to 14:2n-6 in rat liver peroxisomes
(Baykousheva et al. 1994). In the retina, a similar
retroconversion pathway was found to convert 22:5n-3 to
20:5n-3 (Wang and Anderson, 1993). We describe here
experiments designed to determine if retroconversion pathways can
produce 14:1n-9 and 14:2n-6 in the frog retina and if
they are used for N-terminal fatty acylation of G .
EXPERIMENTAL PROCEDURES
AnimalsAdult frogs (Rana pipiens) were
purchased from J. M. Hazen (Alburg, VT). Frogs were housed under a
constant dinural cycle of 10 h of dark and 14 h of light. All animal
care tightly followed the guidelines set by the Association for
Research in Vision and Ophthalmology Resolution for the use of Animals
in Research and the NIH Guide for the Care and Use of Animals in
Research. The experimental protocol was reviewed and approved by the
Animal Protocol Review Committee of Baylor College of Medicine
(Houston, TX).
[ H]Fatty
Acids[9,10- H]14:0 (myristic acid) (31
Ci/mmol) and [9,10- H]18:1n-9 (oleic
acid) (10 Ci/mmol) were purchased from DuPont NEN.
[9,10,12,13- H]18:2n-6 (linoleic acid)
(90 Ci/mmol) and
[9,10,12,13,15,16- H]18:3n-3 (linolenic
acid) (120 Ci/mmol) were from American Radiolabeled Chemicals, Inc.
(St. Louis, MO). Each fatty acid was examined for purity as outlined in
the section ``Fatty Acid Phenacyl Ester Preparation and HPLC
Analysis'' and unless otherwise noted was found to be free of
interfering contaminants. The [ H]fatty acid, 1
mCi total for [ H]-14:0 or
[ H]-18:1n-9 and 120 µCi total for
[ H]-18:2n-6 or
[ H]-18:3n-3, was suspended by sonication
in a 200-µl aliquot of fatty acid-free (<0.003%) bovine serum
albumin (Sigma) in 50 mM NaHCO , such that the
final fatty acid/bovine serum albumin molar ratio was 2:1.
Preparation of Frog RetinasAll dissection
procedures described here were performed under dim red lights.
Dark-adapted frogs (16 h) were killed by decapitation followed by
immediate pithing of the spinal column. Eyes were enucleated and placed
in room temperature Krebs-Ringer buffer (118 mM NaCl, 4.7
mM KCl, 1.17 mM KH PO , 1.17
mM MgSO , 5.6 mMD-glucose, 35
mM NaHCO , and 1.0 mM EDTA, pH 7.4) and
then converted to eyecups through removal of the cornea, lens, and
vitreous humor. Retinas were detached by further incubation (15 min) of
eyecups in room temperature Krebs-Ringer buffer. Retinas were removed
and cleaned of adhering retinal pigmented epithelium using jewelers
forceps and then stored in ice-cold Krebs-Ringer buffer.
Retina in Vitro IncubationAll ensuing incubation
procedures were performed under dim room lighting (50-100 lux).
Dissected frog
retinas(24, 25, 26, 27, 28, 29, 30, 31, 32) were
placed in a flask containing 3.8 ml of oxygenated (1 h with
O /CO (95:5)) Krebs-Ringer buffer supplemented
with 2.5 mM CaCl and antibiotic mixture (final
concentrations, 20 units/ml penicillin G sodium, 20 µg/ml
streptomycin sulfate, and 50 ng/ml Fungizone (Squibb); purchased from
Hazelton Research Products, Lenexa, KS). Retinas were preincubated for
20 min at 24 °C under constant humidified O /CO (95:5) with mild agitation. Incubation was started by addition of
the [ H]fatty acid/bovine serum albumin conjugate
with final concentrations for each medium of 8 mM [ H]-14:0, 25 mM [ H]-18:1n-9, 0.34 mM [ H]-18:2n-6, and 0.25 mM [ H]-18:3n-3. Incubation was
continued for 8 h under the same conditions as the preincubation step.
Incubated retinas were gently washed by four sequential passages
through dishes of ice-cold Ca -plus Krebs-Ringer
buffer and then frozen at -20 °C in d = 1.175
g/ml sucrose buffer (7 mM Tris acetate, pH 7.4, 70 mM NaCl, and 0.7 mM MgCl ).
Preparation of Rod Outer Segments and Retina
MembranesROS were prepared by the method of Louie et
al.(1988). Frozen retinas were thawed and immediately homogenized
in additional d = 1.175 g/ml sucrose buffer containing
1 mM phenylmethylsulfonyl fluoride, which was sequentially
overlaid with d = 1.155 g/ml, 1.135 g/ml, and 1.115
g/ml sucrose buffer (1 mM Tris acetate, pH 7.4, and 0.1 mM MgCl ). After centrifugation at 75,000 g for 90 min, ROS were collected from the d =
1.115/1.135 interface. ROS were washed by 4-fold dilution in Tris
acetate buffer (50 mM Tris acetate, pH 7.4, 5 mM MgCl , 0.1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride) with centrifugation at 27,000
g. Remaining gradient fractions were pooled, diluted,
and pelleted in the same manner to yield retina membranes.
Lipid Extraction and Separation of Lipid
SpeciesMembranes were homogenized in 2 ml of Tris acetate
buffer and extracted twice with 2 ml of CHCl /MeOH/12 N HCl (100:100:1, v/v/v) and once with 1.5 ml of CHCl .
Following centrifugation, the CHCl layers were pooled,
total lipid phosphorus was estimated by the method of Rouser et
al. (1970), and total radioactivity was determined by
scintillation counting. An equal portion of each extract was separated
into phospholipids (phosphatidylcholine, phosphatidylserine,
phosphatidylinositol, and phosphatidylethanolamine classes), free fatty
acids, and triglycerides by TLC (Kupke and Zeugner, 1978) on a silica
gel 60 TLC plate (EM Science), with development up one-third of the
plate with CHCl /MeOH/H O (65:30:5, v/v/v) and
complete development with hexane/Et O/HOAc (80:20:1.5,
v/v/v). For analysis of total radioactivity in each class, positions
were located by I vapor and marked, and after I sublimation, spots were scraped and counted in BCS mixture
(Amersham Corp.) 1N HCl (15:1, v/v). For fatty acid analysis, spots
corresponding to the lipid classes were located by spraying with
2,7-dichlorofluorescein and illuminating with UV and then scraped and
analyzed as described below.
Fatty Acid Phenacyl Ester Preparation and HPLC
AnalysisTotal lipid extracts or isolated lipid classes were
saponified for 45 min at 100 °C in 2% KOH/EtOH (w/v), diluted with
H O, acidified with 12 N HCl, and extracted three
times with hexane. Free fatty acid extracts were used to prepare FAPEs
according to the method of Wood and Lee(1983) as modified by Chen and
Anderson (1993a). FAPEs were separated on HPLC using a Supelco
(Bellefonte, PA) Supelcosil(TM) LC-18 column (25 cm 4.6 mm
I.D.) with elution (2 ml/min) by a linear gradient of
CH CN/H O starting at 80:20 (v/v), increasing to
92:8 in 45 min, holding at 92:8 for 10 min, and returning to 80:20 in 5
min. Elution of FAPEs was monitored by UV absorbance at 242 nm.
Radioactivity profiles were obtained with an on-line continuous
scintillation counter (Flo-One: Radioactive Flow Detector A-200,
Radiomatic, Tampa, FL) using Flo-scint A mixture (Packard Instrument
Co., Inc., Meriden, CT) at a 2.5:1 (v/v) ratio with the column eluant.
Preliminary identification of FAPE peaks was based upon retention times
obtained for FAPEs prepared from radiolabeled and nonradiolabeled fatty
acid standards (Sigma). Fatty acid standards of 14:1n-9,
14:2n-6, and [1- C]14:2n-6 were
generously provided by Dr. Howard Sprecher (Department of Medical
Biochemistry, Ohio State University).
Analysis of FAPEs by Catalytic
HydrogenationIndividual FAPE peaks were collected and extracted
three times with hexane, followed by saponification with 2% KOH/EtOH
(w/v), as described above. Free fatty acids were solubilized in
EtOH/hexane (2:1) and bubbled vigorously with hydrogen (20 min) in the
presence of 10 mg of Pt O (Matheson Coleman & Bell
Manufacturing Chemists, Norwood, OH) catalyst. Spent Pt O
was removed by centrifugation. Hydrogenated fatty acids in the
supernatant were phenacylated as described above, and FAPEs were
chromatographed on HPLC with the modification of a 30-min elution with
100% acetonitrile immediately following the 98:2 acetonitrile/water, to
elute saturated fatty acids larger than 18 carbon atoms.
Isolation of TransducinTransducin was isolated
using a modification of the procedures of Ohguro et al.(1990)
and Umbarger et al.(1992). ROS were homogenized at 4 °C in
isotonic wash buffer (100 mM Tris-HCl, pH 7.5, 5 mM MgCl , 1 mM EGTA, 2 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride)
and centrifuged at 100,000 g for 30 min. The isotonic
buffer wash was repeated once, and the ROS pellet was homogenized at 4
°C in hypotonic wash buffer (5 mM Tris-HCl, pH 7.5, 0.5
mM MgCl , 2 mM dithiothreitol, and 1
mM phenylmethylsulfonyl fluoride) and centrifuged at 100,000
g for 30 min. The ROS pellet was homogenized at 4
°C in hypotonic wash buffer containing 200 µM GTP S and centrifuged at 100,000 g for 30
min. The hypotonic buffer wash with 200 µM GTP S was
repeated once, and the transducin subunits
(G ) were recovered in the GTP S wash
supernatants.
Electrophoresis and H-Fluorography of
TransducinAliquots of the supernatants for the GTP S washes
were made 16% (w/v) in trichloroacetic acid (Fisher) and centrifuged at
27,000 g for 30 min. The protein pellet was
solubilized in strongly reducing sample application buffer (20% (w/v)
sucrose, 2% (w/v) SDS, 50 mM Na CO , pH
9, 50 mM dithiothreitol, 0.3 mM 2-mercaptoethanol,
and 0.15 mM bromphenol blue) and incubated 16 h at 25 °C.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed
according to Laemmli(1970) using 12% (w/v) polyacrylamide gels. Gels
were stained with Coomassie Blue R-250, destained for 2-3 days
with MeOH/HOAc/H O (1:1:8, v/v/v), and photographed. After
washing for 1-2 h in 10% (v/v) HOAc, the gels were treated with
DuPont NEN EN HANCE(TM) following the
manufacturer's instructions. After vacuum drying onto filter
paper, the treated gels were exposed to autoradiography x-ray film at
-80 °C for 4-6 weeks.To test for resistance of
radiolabel of proteins to hydrolysis by hydroxylamine
(NH OH) as evidence of amide linkage, SDS-PAGE was repeated
and gels were treated with NH OH using a modification of the
methods of Buss et al.(1987) and Olson et al.(1985).
The gels were fixed (30 min) in isopropanol/H O/HOAc
(25:65:10, v/v/v), washed (45 min) with H O, soaked (16 h)
in 1 M NH OH HCl (pH 6.7), and washed (6 h)
with isopropanol/H O/HOAc (10:80:10, v/v/v). Gels were
stained, destained, treated with EN HANCE(TM), dried, and
autoradiographed. To determine the efficiency of thioester-linked fatty
acid removal by NH OH, we performed the procedure on
rhodopsin, a protein known to carry two thioester linked 16:0 groups
(Papac et al., 1992). Using previously described procedures,
frog retinas were incubated in vitro with 150 µCi of
[9,10(N)- H]16:0 (American Radiolabeled
Chemicals Inc., St. Louis, MO), and ROS were prepared, stripped of
transducin, and subjected to SDS-PAGE using low reducing conditions (1
h of incubation in sample application buffer containing 2 mM dithiothreitol and 15 µM 2-mercaptoethanol). Gel
slices (n = 4) containing rhodopsin ( 50 µg,
estimated by BCA* protein assay kit, Pierce) were saponified in 1 M NaOH at 37 °C for 2 h and acidified with 12 N HCl,
and radioactivity was determined by counting gel slice and hydrolysate
together (BCS mixture/hydrolysate, 15:1, v/v). Identical gels were
subjected to treatment with 1 M NH OH as described
above; rhodopsin was excised, saponified, and counted. NH OH
treatment removed 84 ± 2% of the radiolabel from this protein.
Fatty Acid Analysis of TransducinSamples of
transducin (n = 3) were subjected to SDS-PAGE and
amounts of G and G in each were
estimated by scanning the gel photographs with a laser densitometer
(Personal Densitometer SI(TM) with ImageQuaNT analysis software,
Molecular Dynamics Inc., Sunnyvale, CA) using a linear proportion
comparison with a known amount of carbonic anhydrase (29 kDa) run on
the same gels. The amounts of G in each were estimated
to be 18 ± 4 (14:0), 24 ± 4 (18:1n-9), 24
± 2 (18:2n-6), and 8 ± 1 µg
(18:3n-3), with corresponding G at 13
± 2, 16 ± 3, 15 ± 2, and 5 ± 1 µg,
respectively. Gel slices containing G and G were washed with MeOH/H O/HOAc (50:40:1, v/v/v) (24
h), 50% MeOH (24 h), and 100% MeOH (2 h). After the addition of 100
nmol 16:1n-9 and 17:0 as carrier, the gel slices were
hydrolyzed in 2 N HCl/83% MeOH for 8 h at 98 °C under
argon gas. The hydrolysate was extracted three times with hexane, and
the fatty acid methyl esters (FAMEs) were chromatographed on HPLC with
UV absorbance being monitored at 192 nm (Aveldano et al.,
1983). The identities of unsaturated FAMEs were confirmed by catalytic
hydrogenation.
RESULTS
Incubation with
[9,10- H]14:0HPLC of FAPEs derived from
the total retinal lipid pool after incubation with
[ H]14:0 (Fig. 1A) revealed only
chain elongation to [ H]16:0 ( 11% of
[ H]14:0) and [ H]18:0
( 7%). A minor peak eluting at 14 min had the identical retention
time as a contaminant that was present in the commercial stock of
[ H]14:0 and therefore is unlikely to represent a
metabolic product of 14:0.
Figure 1:
Incubation with
[9,10- H]14:0. A, HPLC elution profile of
FAPE radioactivity for total lipids extracted from frog retinas
incubated with 1 mCi of [ H]14:0. The y axis ([ H] counts/6-s interval) is shown at a
10 reduction of the original scale; the maximum for
[ H]14:0 peak was 41,900. B, Coomassie
Blue-stained electrophoretic gel (a) and corresponding
fluorogram (b) for transducin (G )
isolated from frog retinas labeled with 1 mCi of
[ H]14:0. Fluorography was performed for 28 days.
G and G are the - and
-subunits of transducin, respectively. The G (8
kDa) was run off the gel. C, HPLC elution profiles of FAME
radioactivity for G and G (control)
isolated from frog retinas labeled with 1 mCi of
[ H]14:0. FAMEs were released from the
SDS-PAGE-purified G and G by acidic
methanolysis.
The Coomassie staining pattern (Fig. 1B, a) and fluorogram (Fig. 1B, b) showed intense radiolabeling at a
migration position in SDS-PAGE aligning precisely with G (39 kDa), and there was no detectable radiolabeling of
G (36 kDa) or any other proteins. HPLC of methanolysis
products (Fig. 1C) confirmed that the radiolabel on
G was 14:0 (481 ± 74 counts/6 s/10 µg),
along with some minor peaks of uncertain identity. A comparatively
insignificant amount of labeled 14:0 was associated with G (18 ± 11 counts/6 s/10 µg).
Incubation with
[9,10- H]18:1n-9HPLC of FAPEs
derived from the total retinal lipid pool after incubation with
[ H]18:1n-9 (Fig. 2A)
revealed only retroconversion to
[ H]14:1n-9 ( 2% of
[ H]18:1n-9) and
[ H]16:1n-9 ( 4%). HPLC of the
retroconversion products after catalytic hydrogenation (Fig. 2A) confirmed their identities by showing an
appropriate shift in retention time to that of 14:0 and 16:0,
respectively. A trace amount of 14:0 was also produced during the
hydrogenation of 16:1n-9.
Figure 2:
Incubation with
[9,10- H]18:1n-9. A, HPLC
elution profile of FAPE radioactivity for total lipids from frog
retinas incubated with 1 mCi of
[ H]18:1n-9. The y axis
([ H] counts/6-s interval) is shown at a 10
reduction of the original scale; the maximum for the
[ H]18:1n-9 peak was at 21,322. Also
shown are the HPLC elution profiles of FAPE radioactivity for the
14:1n-9 and 16:1n-9 after being collected separately
and subjected to catalytic hydrogenation. B, Coomassie
Blue-stained electrophoretic gel (a) and corresponding
fluorogram (b) for transducin (G )
isolated from frog retinas labeled with 1 mCi of
[ H]18:1n-9. Fluorography was performed
for 41 days. G and G are the -
and -subunits of transducin, respectively. G (8
kDa) was run off the gel. C, HPLC elution profiles of FAME
radioactivity for G and G (control)
isolated from frog retinas labeled with 1 mCi of
[ H]18:1n-9. FAMEs were released from the
SDS-PAGE-purified G and G by acidic
methanolysis. Also shown is the HPLC elution profile of FAME
radioactivity for the 14:1n-9 and 18:1n-9 from the
methanolysis of G , after being collected
simultaneously and subjected to catalytic
hydrogenation.
The Coomassie staining pattern (Fig. 2B, a) and fluorogram (Fig. 2B, b) revealed faint radiolabeling
concentrated at a migration position in SDS-PAGE aligning precisely
with G (39 kDa), with some diffuse radiolabeling
extending into the region for G (36 kDa). Another area
of diffuse radiolabeling was observed to be focused at a migration
position aligning with a faint doublet protein band above 84 kDa. HPLC
of methanolysis products (Fig. 2C) showed that the
radiolabel on G was a mixture of 14:1n-9 (108
± 16 counts/6 s/10 µg) and 18:1n-9 (51 ± 6
counts/6 s/10 µg), whereas the radiolabel seen in the region for
G was only 18:1n-9 (35 ± 9 counts/6
s/10 µg). HPLC of the G methanolysis products
after simultaneous collection and catalytic hydrogenation (Fig. 2C) confirmed their identities by showing only
two peaks with appropriate retention times for 14:0 and 18:0 within the
predicted proportions (14:0 (63%) and 18:0 (37%)).
Incubation with
[9,10,12,13- H]18:2n-6HPLC of
FAPEs derived from the total retinal lipid pool after incubation with
[ H]18:2n-6 (Fig. 3A)
revealed retroconversion to [ H]14:2n-6
( 2% of [ H]18:2n-9) and
[ H]16:2n-6 ( 1%), along with
desaturation and elongation to
[ H]18:3n-6,
[ H]20:3n-6, and
[ H]20:4n-6 ( 8, 3, and 7%,
respectively). HPLC of the retroconversion products after catalytic
hydrogenation (Fig. 3A) confirmed their identity by
showing an appropriate shift in retention time to that of 14:0 and
16:0, respectively. A small amount of 18:0 was also produced during the
hydrogention of 16:2n-6, possibly arising from contaminating
18:3n-6. Identities of all desaturation and enlongation
products were also confirmed by catalytic hydrogenation (results not
shown).
Figure 3:
Incubation with
[9,10,12,13- H]18:2n-6. A, HPLC
elution profile of FAPE radioactivity for total lipids from frog
retinas incubated with 120 µCi of
[ H]18:2n-6. The y axis
([ H] counts/6-s interval) of the radioactivity
profile is shown at a 10 reduction of the original scale; the
maximum for the [ H]18:2n-6 peak was at
32,946. Also shown are the HPLC elution profiles of FAPE radioactivity
for the 14:2n-6 and 16:2n-6 after being collected
separately and subjected to catalytic hydrogenation. B,
Coomassie Blue-stained electrophoretic gel (a) and
corresponding fluorogram (b) for transducin
(G ) isolated from frog retinas labeled with
120 µCi of [ H]18:2n-6. Fluorography
was performed for 42 days. G and G are the - and -subunits of transducin, respectively.
G (8 kDa) was run off the gel. C, HPLC
elution profiles of FAME radioactivity for G and
G (control) isolated from frog retina labeled with 120
µCi of [ H]18:2n-6. FAMEs were
released from SDS-PAGE-purified G and G by acidic methanolysis. Also shown is the HPLC elution profile of
FAME radioactivity for the 14:2n-6 from the methanolysis of
G , after being subjected to catalytic
hydrogenation.
The Coomassie staining pattern (Fig. 3B, a) and fluorogram (Fig. 3B, b)
revealed moderate radiolabeling at a migration position in SDS-PAGE
aligning precisely with G (39 kDa), with faint
radiolabeling also seen aligning with G (36 kDa). No
other areas of radiolabeling were observed in the fluorogram. HPLC of
methanolysis products (Fig. 3C) revealed that the
radiolabel on G was only 14:2n-6 (101
± 8 counts/6 s/10 µg), and no detectable radiolabel was
associated with G . Catalytic hydrogenation and HPLC of
the methanolysis product for G confirmed its identity
by showing an appropriate shift in retention time to that of 14:0.
Incubation with
[9,10,12,13,15,16- H]18:3n-3HPLC
of FAPEs derived from the total retinal lipid pool after incubation
with [ H]18:3n-3 (Fig. 4A) revealed the absence of candidate peaks for
the anticipated 14:3n-3 or 16:3n-3 retroconversion
products. Desaturation and elongation products were observed in the
form of [ H]18:4n-3,
[ H]20:5n-3, and
[ H]22:5n-3 ( 12, 8, and 7% of
[ H]18:3n-3, respectively). HPLC of the
18:4n-3 desaturation product after catalytic hydrogenation (Fig. 4A) confirmed its identity by showing an
appropriate shift in retention time to that of 18:0. Likewise,
identities of the other desaturation and elongation products were
confirmed by catalytic hydrogenation (results not shown). Hydrogenation
of the prominent peak at 18 min produced a product with a
retention time between that of 18:0 and 20:0 (result not shown), making
its identification inconclusive.
Figure 4:
Incubation with
[9,10,12,13,15,16- H]18:3n-3. A,
HPLC elution profile of FAPE radioactivity for total lipids from frog
retinas incubated with 120 µCi of
[ H]18:3n-3. The y axis
([ H] counts/6-s interval) of the radioactivity
profile is shown at a 4 reduction of the original scale; the
maximum for the [ H]18:3n-3 peak was at
7086. Also shown are the HPLC elution profiles of FAPE radioactivity
for the 18:4n-3 after being subjected to catalytic
hydrogenation. B, Coomassie Blue-stained electrophoretic gel (a) and corresponding fluorogram (b) for transducin
(G ) isolated from frog retinas labeled with
120 µCi of [ H]18:3n-3. Fluorography
was performed for 35 days. G and G are the - and -subunits of transducin, respectively.
G (8 kDa) was run off the gel. C, HPLC
elution profiles of FAME radioactivity for G and
G (control) isolated from frog retina labeled with 120
µCi of [ H]18:3n-3. FAMEs were
released from SDS-PAGE-purified G and G by acidic methanolysis.
The Coomassie staining pattern (Fig. 4B, a) and fluorogram (Fig. 4B, b) showed no radiolabeling
corresponding with G (39 kDa), G (36
kDa), or any other protein observed on SDS-PAGE. HPLC of methanolysis
products (Fig. 4C) revealed that no detectable
radiolabel was associated with either G or
G , consistent with the fluorogram results.
Hydroxylamine Treatment of Radiolabeled
TransducinShown in Fig. 5are the Coomassie staining
patterns and fluorograms for gels containing transducin from the
[ H]14:0,
[ H]18:1n-9, and
[ H]18:2n-6 incubations, after treatment
with 1 M hydroxylamine. The radiolabelings on G (39 kDa), representative of [ H]14:0,
[ H]14:1n-9/[ H]18:1n-9,
and [ H]14:2n-6, respectively, all showed
hydroxylamine resistance. Complete disappearance of radiolabeling was
observed for G (36 kDa) and all other proteins.
Figure 5:
Hydroxylamine treatment of radiolabeled
transducin. Frog retinas were incubated with either 1 mCi of
[9,10- H] 14:0, 1 mCi of
[9,10- H]18:1n-9, or 120 µCi of
[9,10,12,13- H]18:2n-6. Radiolabeled
retinas were used to prepare rod outer segments. Transducin was
isolated and run on the same electrophoretic gel. The gel was treated
with 1 M hydroxylamine and subsequently subjected to
fluorography for 44 days. Shown here are the Coomassie Blue-stained
electrophoretic gel sections after hydroxylamine treatment and the
corresponding fluorograms. G and G are the - and -subunits of transducin, respectively.
G (8 kDa) was run off the
gel.
Distribution of Desaturation, Elongation, or
Retroconversion Products in Retina Lipid ClassesFig. 6shows the distribution of isotope in the retinal
phospholipid, free fatty acid, and triglyceride pools from the
[ H]-14:0,
[ H]-18:1n-9,
[ H]-18:2n-6, and
[ H]-18:3n-3 incubations. The figure also
shows the composition of radioactivity contained within the individual
lipid classes. In all incubations the majority of the radiolabel was
sequestered in the phospholipid pool after 8 h. We did not examine the
distribution of radioactivity among the various phospholipid classes.
For all incubations, fatty acid analysis of each lipid class revealed
all the previously described desaturation, elongation, or
retroconversion products, with percentages similar to that found when
the total lipid pools were analyzed. There was not a significant
enrichment of any metabolic product into a particular lipid class.
Figure 6:
Distribution of desaturation, enlongation,
or retroconversion products in lipid classes derived from retina
membrane pellets. Total lipids obtained from
[ H]14:0,
[ H]18:1n-9,
[ H]18:2n-6, and
[ H]18:3n-3 radiolabeled retina membranes
were resolved into phospholipids (PL), free fatty acids (FFA), and triglycerides (TG) using one-dimensional
two-step TLC. Lipid classes were directly counted to determine total
radioactivity. Lipid classes were then saponified, and the resulting
fatty acids were converted to phenacyl esters and chromatographed on
HPLC. The data are represented as percentages calculated by taking the
ratio of radioactivity for the individual lipid classes or fatty acid
species to the total radioactivity in the original total lipid extract
or separated lipid class.
DISCUSSION
N-terminal fatty acylation of a protein is carried out
cotranslationally by the enzyme myristoylCoA:protein N-myristoyltransferase (Towler et al., 1988 and
Schlesinger, 1993). Human and yeast myristoyltransferases have a high
substrate specificity for 14:0-CoA (Kishore et al., 1991,
1993; Lu et al., 1994). Although 14:2(n-6)-CoA has
not been tested, 14:1(n-9)-CoA is utilized by both
myristoyltransferases at a 3-fold lower catalytic efficiency (V /K ) than 14:0-CoA
(Kishore et al., 1993). Despite extensive study, no evidence
has been found for myristoyltransferase isozymes with drastically
altered substrate specificity, and supporting this mRNA from the single
copy human gene appears to be identical in all tissues studied (Duronio et al., 1992). Consequently, to successfully compete for
myristoyltransferase, levels of available 14:1n-9 and
14:2n-6 CoAs must be higher than that of 14:0. To attain these
levels, the retina would need to possess special pathways for
generating 14:1n-9 and 14:2n-6, which are apparently
absent or less active in other tissues. However, this does not mean
14:1n-9 and 14:2n-6 would necessarily accumulate in
the retina, because their CoAs might be taken up rapidly by the
myristoyltransferase during active protein synthesis. This hypothesis
is consistent with the lack of detectable (<0.1%) 14:1n-9
and 14:2n-6 in the total lipid pool of the frog and bovine
retina (Chen and Anderson, 1993a; Bartley et al., 1962). We
first tested whether 14:1n-9 and 14:2n-6 might be
generated by de novo synthesis, because the 14:1n-5
isomer can be synthesized via a  -desaturase (Hamosh
and Bitman, 1992; Koletzko et al., 1992), but we found that
14:0 does not serve as a desaturase substrate in the retina and only
16:0 and 18:0 are produced. We next considered that 14:1n-9
and 14:2n-6 might be produced during the -oxidation
(retroconversion) of long chain unsaturated fatty acids. Our
experiments showed that retroconversion of 18:1n-9 and
18:2n-6 leads to the formation of 14:1n-9 and
14:2n-6, respectively, in the frog retina. Interestingly,
18:1n-9 was only metabolized to 14:1n-9 and
16:1n-9, suggesting a restricted function for this fatty acid
in the retina. Our results showed 18:2n-6 has multiple roles
in the retina; it was retroconverted to 14:2n-6 and
16:2n-6 and also underwent extensive elongation and
desaturation, following the steps toward 20:4n-6 as in liver
(Sprecher, 1972). The fatty acid composition of frog retinas (Chen
and Anderson, 1993a) suggests that 18:1n-9 and
16:1n-9 are the likely precursors of 14:1n-9, because
they are the only n-9 fatty acids present in reasonable
abundance (12 and 3% of total fatty acid, respectively). In contrast,
multiple n-6 species are present, with 20:4n-6 being
the most abundant (7%) and 18:2n-6 much less so (1%). Because
rat liver peroxisomes are known to convert 20:4n-6 to
14:2n-6 with 18:3n-6 and 16:3n-6
intermediates (Luthria et al., 1995), 20:4n-6 is a
more likely candidate for the major 14:2n-6 precursor in the
retina. Preliminary results from incubation of
[ H]20:4n-6 (DuPont NEN) with frog
retinas (n = 2) showed production of
[ H]16:3n-6 (3%) and
[ H]14:2n-6 (2%) with no detectable
[ H]18:3n-6 (data not shown), supporting
this hypothesis. N-terminal acylated retina proteins do not contain
14:3n-3 (Johnson et al. 1994), even though n-3 polyunsaturated fatty acids are abundant in the vertebrate
retina (Fliesler and Anderson, 1983). We found that metabolism of
[ H]18:3n-3 did not produce detectable
[ H]16:3n-3 or
[ H]14:3n-3 retroconversion products and
radiolabel was not incorporated into G . This result
shows that the retroconversion process in the frog retina has a
selectivity dependent on double bond position, as well as on chain
length. The 18:3n-3 did undergo extensive elongation and
desaturation, following the steps toward 22:6n-3, as described
for liver (Sprecher, 1972), consistent with previous observations in
the frog retina (Wang and Anderson, 1993). Under the in vitro incubation conditions we used, there was an active uptake and
metabolism for all the radiolabeled fatty acids, as indicated by the
amount of the original starting radioactivity that was incorporated
into the retina glycerolipids ([ H]14:0, 12%;
[ H]18:1n-9, 14%;
[ H]18:2n-6, 5%; and
[ H]18:3n-3, 7%). In all incubations, the
phospholipids contained most of the radiolabel, whereas only a small
percentage was incorporated into triglycerides, consistent with
previous studies (Wang and Anderson, 1993; Chen and Anderson, 1993b).
Incorporation into glycerolipids indicates effective conversion to
precursor CoA ester derivatives. Acyl-CoAs are also the substrates for
myristoyltransferase, and labeling of G with
[ H]14:0 suggested efficient conversion to the CoA
ester. In addition to incorporation of
[ H]14:0,
[ H]14:1n-9, and
[ H]14:2n-6 into G , we
also noted some labeling with
[ H]18:1n-9. We have not determined
whether this represents N-terminal acylation by myristoyltransferase,
which in yeast can utilize 18:1n-5 2% as effectively as
14:0 (Rudnick et al., 1992), or trace labeling by
thioesterification or some other means. Our ability to incorporate
[ H]14:2n-6 into frog G is consistent with the data of Johnson et al.(1994),
which shows 100% modification with 14:2n-6. The incorporation
of [ H]14:0 and
[ H]14:1n-9 into G indicates that at least some G in frog retina
can be modified with these fatty acids, possibly at levels too low to
be detected by mass spectrometry. Amide linkage of the
[ H]14:0,
[ H]14:1n-9, and
[ H]14:2n-6 to G was
supported by finding that the radiolabel was resistant to
hydroxylamine, under conditions where 86% removal of rhodopsin's
thioester-linked fatty acid was achieved. Taken together with the mass
spectrometric results of Johnson et al.(1994) and the well
established specificity of myristoyltransferase in yeast and mammals,
this result strongly suggests that the most likely site for attachment
of these fatty acids is the -amino group of the N-terminal glycine
of frog G . Because frog G is
reported to be modified exclusively by 14:2n-6, we
investigated whether radiolabeled 14:2n-6 would directly
incorporate into the protein. We performed in vitro incubations (n = 2) of frog retinas with 20
µCi of [1- C]14:2n-6 (data not
shown). Analysis of the retina total lipids showed significant chain
elongation of the [ C]14:2n-6 to
[ C]16:2n-6 and
[ C]18:2n-6 (3 and 4% of
[ C]14:2n-6, respectively). Metabolism
of nonradiolabeled 14:2n-6 to 16:2n-6 and
18:2n-6 has been previously noted in rat liver (Sprecher,
1967). Methanolysis of SDS-PAGE-purified G (19
± 2 µg) and G (13 ± 1 µg) from
the [ C]14:2n-6 labeled retinas failed
to release any detectable radiolabeled fatty acids. Because the
[ C]14:2n-6 used in our incubations was
of very low specific activity (55-60 Ci/mol), it is possible that
dilution with endogenously produced 14:2n-6 precluded our
detecting radioactivity in protein product. However, it is also
possible that 14:2n-6 supplied directly may not be readily
available as a substrate for myristoyltransferase to incorporate into
G . It is clearly converted into the necessary chemical
form, CoA ester, as evidenced by chain elongation products and its
incorporation into glycerolipids. However, subcellular
compartmentalization may limit the access of myristoyltransferase and
the nascent G polypeptide to 14:2n-6 when it
is supplied directly, while allowing free access to the
14:2n-6 pool produced by retroconversion. The fatty acid
retroconversions seen in our experiments have the limited chain
shortening characteristics associated with peroxisomal -oxidation
(Schulz, 1991), as shown by the lack of production of 12:1n-9
and 12:2n-6 or other short chain fatty acids. In support of
this are electron microscopy studies showing that
Müller and photoreceptor cells of frog retinas
contain significant peroxisome-like organelles (St. Jules et
al., 1992). However, more experiments are necessary to determine
where the observed -oxidation occurs. Retina peroxisomes may prove
to be more vigorous or less stringent in retroconverting these fatty
acids compared with those from other tissues. Such differences may
account for the absence of 14:1n-9 or 14:2n-6 on
myristoylated liver proteins such as cytochrome b reductase
(Ozols et al., 1984), even though liver peroxisomes carry out
fatty acid retroconversions. Although we do not know the functional
significance for N-terminal fatty acylation of photoreceptor proteins
with unsaturated forms of myristate, the retroconversion pathways we
have investigated could play a major role in both normal visual
function and retinal disease states. Congenital defects such as
adrenomyelnoneuropathy (Moser et al., 1987), neonatal
adrenoleukodystrophy (Jaffe et al., 1982), infantile
Refsum's disease (Poll-the et al., 1987), and Zellweger
syndrome (Bowen et al., 1964) are known afflictions where
peroxisomal -oxidation is impaired. The general phenotype of these
diseases is deterioration of nervous system, often involving the
retina. These symptoms may arise in part from impairment of the
biosynthesis of docosahexaenoic acid (22:6n-3) (Martinez et al., 1994), an essential component of neuronal cells
including retina photoreceptors, which requires the peroxisomal based
retroconversion of 24:6n-3 to 22:6n-3 (Voss et
al., 1991). Because N-terminal fatty acylation with
14:1n-9 and 14:2n-6 may be required for proper
function of phototransduction proteins, impairment of 14:1n-9
or 14:2n-6 production could also have a devastating effect on
normal visual function. It is known that many types of retinal
degeneration involve lipidated phototransduction proteins, such as
rhodopsin (autosomal dominant and autosomal recessive retinitis
pigmentosa) (Dryja et al., 1990; Rosenfeld et al.,
1992) and the -subunit of cGMP phosphodiesterase (PDE )
(autosomal recessive retinitis pigmentosa) (McLaughlin et al.,
1993). A specific example of defective protein lipidation in retinal
degeneration is choroideremia, whose basis is a mutation in
geranylgeranyl transferase (Seabra et al., 1993), the enzyme
that isoprenylates PDE and G proteins of the Rab family.
Therefore, genes encoding proteins involved in the pathways required
for heterogeneous fatty acylation of retina protein warrant further
consideration as retinal degeneration candidates.
FOOTNOTES
- *
- This work was supported by NEI National Institutes
of Health Grants EY07001, EY00871, EY04149, and EY02520 (to R. E. A.)
and EY07981 (to T. G. W.), by grants from the Retina Research
Foundation, by Research to Prevent Blindness Inc., by the National
Retinitis Pigmentosa Foundation Inc., by the Samuel Roberts Nobel
Foundation, Inc., and by the Presbyterian Health Foundation. The costs
of publication of this article were defrayed in part by the payment of
page charges. This article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
The work presented in
this paper is based on platform presentations given by James C. DeMar,
Jr., at the 86th American Oil Chemists Society 1995 Annual Meeting, San
Antonio, TX and the Association for Research in Vision and
Ophthalmology 1995 Annual Meeting, Ft. Lauderdale, FL. - §
- Recipient of 1995 Honored Student and
Outstanding Paper Presentation awards from the American Oil Chemists
Society and a 1995 Association for Research in Vision and
Ophthalmology/National Eye Institute Travel Fellowship.
- ¶
- To whom correspondence should be addressed:
Dean A. McGee Eye Inst., 608 Stanton L. Young Blvd., Oklahoma City, OK
73104. Tel.: 405-271-8250; Fax: 405-271-8128.
- (
) - The abbreviations used are: G
,
transducin -subunit; FAME, fatty acid methyl ester; FAPE, fatty
acid phenacyl ester; G , transducin -subunit;
G , transducin -subunit; HPLC, high pressure
liquid chromatography; PAGE, polyacrylamide gel electrophoresis; ROS,
rod outer segments; GTP S, guanosine
5`-3-O-(thio)triphosphate.
REFERENCES
- Aveldano, M.
I., VanRollins, M., and Horrocks, L. A. (1983) J.
Lipid Res. 24, 83-93
[Abstract]
- Bartley, W., Van
Heyningen, R., Notton, B. M., and Renshaw, A. (1962) Biochem. J. 85, 332-335
[Medline]
[Order article via Infotrieve]
- Baykousheva, S. P.,
Luthria, D. L., and Sprecher, H. (1994) J. Biol. Chem. 269, 18390-18394
[Abstract/Free Full Text]
- Bowen, P., Lee, C. M. S.,
Zellweger, H., and Lindenberg, R. (1964) Bull. Johns
Hopkins Hosp. 114, 402-414
[Medline]
[Order article via Infotrieve]
- Buss, J. E., Mumby, S.
M., Casey, P. J., Gilman, A. G., and Sefton, B. M. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7493-7497
[Abstract/Free Full Text]
- Carr, S. A., Biemann, K.,
Shoji, S., Parmelee, D. C., Titani, K. (1982) Proc.
Natl. Acad. Sci. U. S. A. 79, 6128-6131
[Abstract/Free Full Text]
- Chen, H., and Anderson,
R. E. (1993a) J. Chromatogr. 578, 124-129
- Chen, H., and Anderson,
R. E. (1993b) Curr. Eye Res. 12, 851-860
[Medline]
[Order article via Infotrieve]
- Cook, H. W., Byers, D.
M., Palmer, F. B., Spence, M. W., Rakoff, H., Duval, S. M., and Emken,
E. A. (1991) J. Lipid Res. 32, 1265-1272
[Abstract]
- Dizhoor, A. M.,
Ericsson, L. H., Johnson, R. S., Kumar, S., Olshevskaya, E., Zozulya,
S., Neubert, T. A., Stryer, L., Hurley, J. B., and Walsh, K. A. (1992) J. Biol. Chem. 267, 16033-16036
[Abstract/Free Full Text]
- Duronio, R. J., Reed, S.
I., Gordon, J. I. (1992) Proc. Natl. Acad. Sci. U. S.
A. 89, 4129-4133
[Abstract/Free Full Text]
- Dryja, T. P., Mcgee, T.
L., Hahn, L. B., Cowley, G. S., Olsson, J. E., Reichel, E., Sandberg,
M. A., and Berson, E. L. (1990) N. Engl. J. Med. 323, 1302-1307
[Abstract]
- Fliesler, S. J., and
Anderson, R. E. (1983) Prog. Lipid Res. 22, 79-131
[CrossRef][Medline]
[Order article via Infotrieve]
- Gordon, J. I., Duronio,
R. J., Rudnick, D. A., Adams, S. P., and Gokel, G. W. (1991) J. Biol. Chem. 266, 8647-8650
[Free Full Text]
- Hadjuagapiiou, C.,
Travers, J., Fertel, R., and Sprecher, H. (1990) Biochim. Biophys. Acta 1046, 167-172
[Medline]
[Order article via Infotrieve]
- Hamosh, M., and Bitman,
J. (1992) Lipids 27, 848-857
[CrossRef][Medline]
[Order article via Infotrieve]
- Hansen, H. S. (1993) Trends Biochem. Sci. 18, 164
- Jaffe,
R., Crumine, P., Hashida, Y., and Moser, H. W. (1982) Am. J. Pathol. 108, 100-111
[Abstract]
- James, G., and Olson, E.
N. (1990) Biochemistry 29, 2625-2635
- Johnson, R. S., Ohguro,
H., Palczewski, K., Hurley, J. B., Walsh, K. A., and Neubert, T. A. (1994) J. Biol. Chem. 269, 21067-21071
[Abstract/Free Full Text]
- Jones, T. L. Z.,
Simonds, W. F., Merendino, J. J., Jr., Brann, M. R., and Spiegel A. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 568-572
[Abstract/Free Full Text]
- Kishore, N. S., Lu T.,
Knoll, L. J., Katoh, A., Rudnick, D. A., Mehta, P. P., Devadas, B.,
Huhn, M., Atwood, J. L., Adams, S. P., Gokel, G. W., and Gordon, J. I. (1991) J. Biol. Chem. 266, 8835-8855
[Abstract/Free Full Text]
- Kishore, N. S., Wood, D.
C., Mehta, P. P., Wade, A. C., Lu, T., Gokel, G. W., and Gordon, J. I. (1993) J. Biol. Chem. 268, 4889-4902
[Abstract/Free Full Text]
- Kokame, K., Fukada, Y.,
Yoshizawa, T., Takao, T., and Shimonishi, Y. (1992) Nature 359, 749-752
[CrossRef][Medline]
[Order article via Infotrieve]
- Koletzko, B., Thiel, I.,
and Springer, S. (1992) Eur. J. Clin. Nutr. 46, (Suppl. 4) 45-55
- Kupke, I. R., and
Zeugner, S. (1978) J. Chromatogr. 146, 261-271
[Medline]
[Order article via Infotrieve]
- Kurono, G., Nishikawa,
Y., Miyano, S., and Aburano, S. (1972) Chem. & Pharm. Bull. (Tokyo) 20, 559-563
- Laemmli, U. K. (1970) Nature 227, 680-685
[CrossRef][Medline]
[Order article via Infotrieve]
- Linder, M. E., Pang, I.
H., Duronio R. J., Gordon, J. I., Sternweis, P. C., and Gilman A. G. (1991) J. Biol. Chem. 266, 4654-4659
[Abstract/Free Full Text]
- Louie, K., Wiegand, R.
D., and Anderson, R. E. (1988) Biochemistry 27, 9014-9020
[CrossRef][Medline]
[Order article via Infotrieve]
- Lu, T., Li, Q., Katoh,
A., Hernandez,. J., Duffin, K., Jackson-Machelski, E., Knoll, L. J.,
Gokel G. W., and Gordon, J. I. (1994) J. Biol Chem. 269, 5346-5357
[Abstract/Free Full Text]
- Luthria, D. L.,
Baykousheva, S. P., and Sprecher, H. (1995) J. Biol.
Chem. 270, 13771-13776
[Abstract/Free Full Text]
- Markley, K. S. (1960) Fatty Acids: Their Chemistry,
Properties, Production, and Uses , Part 1, p. 12, Interscience
Publishers, Inc., New York
- Martinez, M., Mougan,
I., Roig, M., and Ballabriga, A. (1994) Lipids. 29, 273-280
[CrossRef][Medline]
[Order article via Infotrieve]
- McIlhinney, R. A. J. (1990) Trends Biochem. Sci. 15, 387-391
[CrossRef][Medline]
[Order article via Infotrieve]
- McLaughlin, M. E.,
Sandberg, M. A., Berson, E. L., and Dryja, T. P. (1993) Nat. Genet. 4, 130-134
[CrossRef][Medline]
[Order article via Infotrieve]
- Moser, H. W., Naidu, S.,
Kumar, A. J., and Rosenbaum, A. E. (1987) Crit. Rev.
Neurobiol. 21, 240-249
- Neubert, T. A., Johnson,
R. S., Hurley, J. B., and Walsh, K. A. (1992) J. Biol.
Chem. 267, 18274-18277
[Abstract/Free Full Text]
- Numa,
S., Jeffcoat, R., and James, A. T. (1984) in Fatty Acid Metabolism
and Its Regulation (Numa, S., ed) pp. 93-96, Elsevier
Science Publishers B.V., Amsterdam
- Ohguro, H., Fukada, Y.,
Saito, T., and Akino, T. (1990) Comp. Biochem.
Physiol. 4, 763-765
- Olson, E. N., Towler, D.
A., and Glaser, L. (1985) J. Biol. Chem. 260, 3784-3790
[Abstract/Free Full Text]
- Oulhaj, H., Huynh, S.,
and Nouvelot, A. (1992) Comp. Biochem. Physiol. 4, 897-904
- Ozols, J., Carr, S. A.,
and Strittmatter, P. (1984) J. Biol. Chem. 259, 13349-13354
[Abstract/Free Full Text]
- Palczewski, K.,
Subbaraya, I., Gorczyca, W. A., Helekar, B. S., Ruiz, C. C., Ohguro,
H., Huang, J., Zhao, X., Crabb, J. W., Johnson, R. S., Walsh, K. A.,
Gray-Keller, M. P., Detwiler, P. B., and Baehr, W. (1994) Nueron 13, 395-404
- Papac, D. I., Thornburg,
K. R., Bullesbach, E. E., Crouch, R. K., and Knapp, D. R. (1992) J. Biol. Chem. 267, 16889-16894
[Abstract/Free Full Text]
- Poll-the, B. T.,
Saudubray, J. M., Ogier, H. A. M., Odievre, M., Scotto, J. M., Monnens,
l., Govaerts, L. C. P., Roels, F., Cornelis A., Schutgens, R. B. H.,
Wanders, R. J. A., Scram, A. W., and Tager, J. M. (1987) Eur. J. Pediatr. 146, 477-483
[CrossRef][Medline]
[Order article via Infotrieve]
- Rudnick, D. A., Lu, T.,
Jackson-Machelski, E., Hernandez, J. C., Li, Q., Gokel, G. W., and
Gordon, J. I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10507-10511
[Abstract/Free Full Text]
- Rosenfeld, P. J.,
Cowley, G. S., McGee, T. L, Sandberg, M. A., Berson, E. L., and Dryja,
T. P. (1992) Nat. Genet. 1, 209-213
[CrossRef][Medline]
[Order article via Infotrieve]
- Rouser, G., Fliescher,
S., and Yamamoto, A. (1970) Lipids 5, 494-500
[Medline]
[Order article via Infotrieve]
- Schlesinger, M. J. (1993) in Lipid Modifications of Proteins , pp. 23-25 and 62, CRC
Press, Inc., Boca Raton, FL
- Schulz, H. (1991) Biochim. Biophys. Acta 1081, 109-120
[Medline]
[Order article via Infotrieve]
- Seabra, M. C., Brown, M.
S., and Goldstein, J. L. (1993) Science 259, 377-381
[Abstract/Free Full Text]
- Sprecher H. (1967) Lipids 3, 14-20
- Sprecher H. (1972) Fed. Proc. 31, 1451-1457
[Medline]
[Order article via Infotrieve]
- St. Jules, R., Kennard,
J., Setlik, W., and Holtzman, E. (1992) Exp. Eye Res. 54, 1-8
[CrossRef][Medline]
[Order article via Infotrieve]
- Towler, D. A., Gordon,
J. I., Adams, S. P., and Glaser, L. (1988) Annu. Rev.
Biochem. 57, 69-99
[CrossRef][Medline]
[Order article via Infotrieve]
- Umbarger, K. O.,
Yamazaki, M., Hutson, L. D., Hayashi, F., and Yamazaki, A. (1992) J. Biol. Chem. 267, 19494-19502
[Abstract/Free Full Text]
- Voss, A., Reinhart, M.,
Sankarappa, S., and Sprecher, H. (1991) J. Biol. Chem. 266, 19995-20000
[Abstract/Free Full Text]
- Wang, N., and Anderson,
R. E. (1993) Biochemistry 32, 13703-13709
[CrossRef][Medline]
[Order article via Infotrieve]
- Wedegaertner, P. B.,
Wilson, P. T., and Bourne, H. R. (1995) J. Biol. Chem. 270, 503-506
[Free Full Text]
- Wood, R., and Lee, T. (1983) J. Chromatogr. 254, 237-243
[CrossRef]
- Yang, Z., and Wensel, T.
G. (1992) J. Biol. Chem. 267, 23197-23201
[Abstract/Free Full Text]
- Yonemoto, W., McGlone,
M. L., and Taylor, S. S. (1993) J. Biol. Chem. 268, 2348-2352
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. P. Chapple, A. J. Hardcastle, C. Grayson, L.A. Spackman, K. R. Willison, and M. E. Cheetham
Mutations in the N-terminus of the X-linked retinitis pigmentosa protein RP2 interfere with the normal targeting of the protein to the plasma membrane
Hum. Mol. Genet.,
August 12, 2000;
9(13):
1919 - 1926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Mata, J. Weng, and G. H. Travis
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration
PNAS,
June 13, 2000;
(2000)
130110497.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. J. Melia, J. A. Malinski, F. He, and T. G. Wensel
Enhancement of Phototransduction Protein Interactions by Lipid Surfaces
J. Biol. Chem.,
February 4, 2000;
275(5):
3535 - 3542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fang, T. L. Kaduce, and A. A. Spector
13-(S)-Hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells
J. Lipid Res.,
April 1, 1999;
40(4):
699 - 707.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. E. Williard, T. L. Kaduce, S. D. Harmon, and A. A. Spector
Conversion of eicosapentaenoic acid to chain-shortened omega–3 fatty acid metabolites by peroxisomal oxidation
J. Lipid Res.,
May 1, 1998;
39(5):
978 - 986.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. C. DeMar Jr. and R. E. Anderson
Identification and Quantitation of the Fatty Acids Composing the CoA Ester Pool of Bovine Retina, Heart, and Liver
J. Biol. Chem.,
December 12, 1997;
272(50):
31362 - 31368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Luthria, B. S. Mohammed, and H. Sprecher
Regulation of the Biosynthesis of 4,7,10,13,16,19-Docosahexaenoic Acid
J. Biol. Chem.,
July 5, 1996;
271(27):
16020 - 16025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Mata, J. Weng, and G. H. Travis
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration
PNAS,
June 20, 2000;
97(13):
7154 - 7159.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|